课题基金 / 基金详情

Role of chylomicron remnants in vascular remodeling

Role of chylomicron remnants in vascular remodeling
乳糜微粒残余物在血管重塑中的作用
批准号:
13670711
负责人:
ISHIKAWA Yuichi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

ISHIKAWA Yuichi的其他基金

相似基金

相关文献

中文摘要
翻译
所有形式的经皮冠状动脉介入治疗都会对血管造成损伤。动脉对损伤的反应是长期预后的基础。血管成形术时,血栓、炎症、内膜和内侧夹层以及动脉壁的弹性回缩会导致新生内膜的形成。乳糜粒残留物是餐后高脂血症的主要脂蛋白,被认为是致动脉粥样硬化的脂蛋白。然而,乳糜管残留物促进动脉粥样硬化的机制还不完全清楚。在这里,我们研究了乳糜管残留物对内皮细胞和平滑肌细胞的影响。我们从饲喂蛋液的大鼠的淋巴中制备乳杆菌微粒,并从注射乳糜微粒的功能性肝切除大鼠的血浆中获得乳杆菌微粒残留物。首先,我们研究了乳糜管残留对人脐静脉内皮细胞(HUVEC)的影响。乳清蛋白残留物激活Caspase-3活性和…更多地诱导HUVECs凋亡,呈剂量依赖关系。接下来,我们研究了乳糜管残留物对培养的血管平滑肌细胞单核细胞趋化蛋白-1(MCP-1)表达的影响。单核细胞趋化蛋白-1(MCP-1)是一种趋化因子,可刺激单核细胞迁移,在动脉粥样硬化的发生发展中起关键作用。乳清蛋白残留物处理VSMC后,MCP-1mRNA和蛋白表达显著增加,并呈时间和剂量依赖关系。此外,乳糜管残留物还激活了p38丝裂原活化蛋白激酶(MAPK)和细胞外信号调节激酶(ERK1/2)。P38 MAPK抑制剂SB203580和SB202190可剂量依赖性地抑制乳糜管残留物诱导的MCP-1mRNA和蛋白表达,而MAPK抑制剂(PD98059)对此无影响。乳糜粒残留物诱导的MCP-1分泌比乳糜粒、氧化型低密度脂蛋白或溶血磷脂酰胆碱诱导的要明显得多。Ohylomicron残留物可能通过诱导内皮细胞凋亡和刺激VSMCs表达MCP-1而加重动脉粥样硬化。较少
英文摘要
All forms of percutaneous coronary intervention confer injury on the vessel. The arterial response to that injury is the basis for long-term outcome. Neointima forms in response to thrombus, inflammation, intimal and medial dissections, and elastic recoil of the arterial wall when augioplasry was performed. Chylomicron remnants, major lipoproteins at postprandial hyperlipidemia, is considered to be proatherogenic lipoproteins. However, the mechanisms by which chylomicron remnants enhance atherosclerosis have not been fully understood. Here, we examined the effect of chylomicron remnants on endothelial cells and smooth muscle cells. We prepared chylomicrons from the lymph of the rats which were fed with egg solution and obtained chylomicron remnants from the plasma of functionally hepatectomized rats injected with chylomicrons. First, we examined the effect of chylomicron remnants on human umbilical vein endomelial cells (HUVECs). Chylomicron remnants activated caspase-3 activity and in … More duced apoptosis of HUVECs in a dose dependent manner. Next, we investigated the effect of chylomicron remnants on monocyte chemoattractant protein-1 (MCP-1) expression in cultured vascular smooth muscle cells (VSMCs). MCP-1 is a chemokine, which stimulates migration of monocytes and plays a critical role in the development of atherosclerosis. Treatment of VSMC with chylomicron remnants significantly increased the expression of MCP-1 mRNA and protein in a time-and dose-dependent manner. Furthermore, chylomicron remnants activated p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK1/2). Pretreatment of VSMCs with p38 MAPK inhibitors,SB203580 and SB202190, dose-dependently inhibited chylomicron remnants-induced MCP-1 mRNA and protein expression,whereas a MAPK kinase inhibitor (PD98059) had no effect on these responses. Chylomicron remnants-induced MCP-1 secretion into the media was much more pronounced than those induced by chylomicrons, oxidized low-density lipoproteins, or lysophosphatidylcholine. Ohylomicron remnants may exacerbate atherosclerosis by inducing endothelial cell apoptosis and stimulating MCP-1 expression in VSMCs. Less
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
Takaishi H, Taniguchi T, Takahashi A, Ishikawa Y, Yokoyama M.: "High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells"Biochem Biophys Res Commun 2003 May 23. 305(1). 122-128
Takaishi H、Taniguchi T、Takahashi A、Ishikawa Y、Yokoyama M.:“高葡萄糖通过血管内皮细胞中的 p38 MAPK 加速 MCP-1 的产生”Biochem Biophys Res Commun 2003 年 5 月 23 日 305(1)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kawashima S, Yamashita T, Ozaki M, Ohashi Y, Azumi H, Inoue N, Hirata K, Hayashi Y, Itoh H, Yokoyama M: "Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling"Arterioscler Thromb Vasc Biol. 21(2). 201-207 (
Kawashima S、Yamashita T、Ozaki M、Ohashi Y、Azumi H、Inoue N、Hirata K、Hayashi Y、Itoh H、Yokoyama M:“内皮 NO 合酶过度表达抑制血管重塑小鼠模型中的病变形成”Arterioscler Thromb Vasc Biol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
谷口 隆弘: "レムナントと動脈硬化"Athero-thrombosis. 7・1. 36-38 (2001)
Takahiro Taniguchi:“残余物和动脉硬化” 7・1(2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
谷口 隆弘: "冠動脈形成術後再狭窄の薬物療法"Molecular Medicine. 38. 281-286 (2001)
Takahiro Taniguchi:“冠状动脉血管成形术后再狭窄的药物治疗”《分子医学》38. 281-286 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 17 条
    Regulation of cytoplasmic HDACs relating HSP90 protein
    • 批准号:
      25860965
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.25万
    • 财政年份:
      2013
    • 负责人:
      ISHIKAWA Yuichi
    • 依托单位:
    A study based on geographical research of TOD in middle-sized cities in local areas
    • 批准号:
      23520963
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.0万
    • 财政年份:
      2011
    • 负责人:
      ISHIKAWA Yuichi
    • 依托单位:
    Creating a New Functional Fluid stemming from the Mixture of"Ionic Liquid - Magnetic particle - Nano Carbon"
    • 批准号:
      23655181
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2011
    • 负责人:
      ISHIKAWA Yuichi
    • 依托单位:
    Synthesis of novel inhibitors of hypoxia-inducible factor-1 transcriptional pathway based on natural products
    海外基金